悦心健康：通过外延并购与公司大健康业务相协同的优质标的是公司董事会既定的发展战略

Stock Star · Mar 27 12:51

证券之星消息，悦心健康(002162)03月26日在投资者关系平台上答复投资者关心的问题。

投资者提问：公司近期有并购计划。

悦心健康回复：您好！通过外延并购与公司大健康业务相协同的优质标的是公司董事会既定的发展战略，公司将长期持续关注合适的并购标的。

以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Recommended

Bank of America surged over 4%! Net income in Q1 increased by 11% year-on-year, with both net interest and Stocks trading rev…

wallstreetcn · Apr 15, 2025 13:36
Blackrock, Fidelity, Schroders... asset management giants shift their investment focus towards defensive assets.

Brokerage China · Apr 15, 2025 14:50
There is "zero progress" in the EU-US trade negotiations: the European Union expects the USA to maintain tariffs.

Golden10 Data · Apr 15, 2025 15:01
Before the government officially announced the suspension of reciprocal tariffs, Trump's allies made significant purchases of S…

cls.cn · Apr 15, 2025 14:39
Precise bottom fishing? Before Trump suspended reciprocal tariffs, key figures in the USA Republican Party bought Apple, A…

Zhitong Finance · Apr 15, 2025 15:03

Write a comment

悦心健康：通过外延并购与公司大健康业务相协同的优质标的是公司董事会既定的发展战略

Market Insights

Investment Course

Latest

悦心健康：通过外延并购与公司大健康业务相协同的优质标的是公司董事会既定的发展战略

Risk Disclaimer

Market Insights

Investment Course

Latest

Statement